Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
Ebiomedicine|February 10, 2019
Specific V-ATPase expression sub-classifies IDHwt lower-grade gliomas and impacts glioma growth in vivoAndrea Terrasi, Irene Bertolini, Cristina Martelli, et al.Journal of Neuro-Oncology|November 7, 2019
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016Roberta Rudà, Alessia Pellerino, Andrea Pace, et al.Frontiers in Oncology|September 30, 2022
Diffusion tensor imaging, intra-operative neurophysiological monitoring and small craniotomy: Results in a consecutive series of 103 gliomasGiorgio Carrabba, Giorgio Fiore, Andrea Di Cristofori, et al.Cancers|January 11, 2022
Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in GlioblastomaLaura Guarnaccia, Giovanni Marfia, Matteo Maria Masseroli, et al.Journal of Neuro-Oncology|September 27, 2019
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016Roberta Rudà, Alessia Pellerino, Andrea Pace, et al.Journal of the Neurological Sciences|August 14, 2020
Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology departmentRolando Campanella, Laura Guarnaccia, Manuela Caroli, et al.Frontiers in Oncology|October 10, 2022
Indication and eligibility of glioma patients for awake surgery: A scoping review by a multidisciplinary perspectiveGiorgio Fiore, Giorgia Abete-Fornara, Arianna Forgione, et al.Oncotarget|May 29, 2015
The vacuolar H+ ATPase is a novel therapeutic target for glioblastomaAndrea Di Cristofori, Stefano Ferrero, Irene Bertolini, et al.Oncotarget|September 17, 2017
Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation statusChiara Pesenti, Leda Paganini, Laura Fontana, et al.World Neurosurgery|August 26, 2018
Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related SignalingStefania Elena Navone, Laura Guarnaccia, Chiara Cordiglieri, et al.Pageof 6